3rd Quarter - Report

LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

S. 822: Justice for All Reauthorizatio Act of 2013: Provisions regarding Debbie Smith DNA backlog.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 822 (113th)

Copyright/Patent/Trademark CPT

H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 1013 (113th), H.R. 845 (113th)

Medicare/Medicaid MMM

Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics.

LobbyistCovered position, as disclosed
AMY MUHLBERG N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Immigration IMM

S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 744 (113th)

Medical/Disease Research/Clinical Labs MED

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A
AMY MUHLBERG N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3005 (113th), H.R. 2085 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.